MoneyWorks4Me

Nectar Lifesciences informs about revised proceedings of 31st AGM

19 Sep 2026 Evaluate
Nectar Lifesciences has informed that this is in continuation of disclosure by the Company vide letter no. NLL/CS/2026- 730 dated September 18, 2026. In this regard pursuant to regulation 30 of Securities and Exchange of Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, (LODR Regulations) it has enclosed revised proceedings of AGM held on Friday, September 18, 2026. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..